In a 48-patient phase 1b trial, ecnoglutide was well tolerated in adolescents with obesity and reduced BMI up to 12.6% at 20 weeks.
|Articles|January 1, 2004
That growing obesity problem--What to do?
Q In keeping with the national trend, I've noticed that more and more of my school-age and adolescent patients are becoming overweight.
Advertisement
Advertisement
Related to this article
Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.
The FDA approved insulin icodec-abae for children 10+ with T2D, based on adult ONWARDS data and a single-dose pediatric pharmacokinetic study.
Johanna Chang, MD, offers guidance on vaccination, infection prophylaxis, and clinical warning signs in children receiving biologic therapies.
Adding emotion skills to family-based weight treatment didn't boost teen weight loss but cut regain and emotional eating 12 months later.
Nikta Forghani, MD, explains when irregular menstrual cycles warrant evaluation and how pediatricians can identify PCOS and relative energy deficiency.
FDA draft guidance proposes cadmium limits of 10 to 45 ppb for processed foods for children younger than 2, from purees to dry infant cereals.
Lower maternal PlGF in the third trimester was tied to child ADHD in a University of Iowa cohort, independent of preeclampsia and FGR.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FAQ: How should pediatricians manage UTIs under new AAP guidance?
2
Family-focused behavioral care tied to better HbA1c in pediatric T1D
3
Recognizing skin conditions in children with darker skin tones
4
FDA proposes cadmium action levels for baby food under Closer to Zero
5